Ratio Therapeutics
Latest round
- Series C
Last raised
- Jul 2026
Total raised
- $70M
Investors
- 5
About Ratio Therapeutics
Based in Massachusetts, US, and founded in 2021 by CEO Jack Hoppin and Director John Babich, Ratio Therapeutics, Inc. operates as a provider of radiotherapeutics treatment and diagnostics by leveraging a technology platform. In July 2026, Ratio Therapeutics, Inc. Ratio Therapeutics provides the technology platform trillium, which incorporates a tunable structural motif enabling compounds to reversibly bind to albumin, thereby modulating pharmacokinetics (PK) and improving drug availability and tumour delivery. In addition, the company offers the macropa technology platform, which is used to convert the alpha-emitting radionuclide actinium-225 to trillium and other compounds. The platform provides small molecules, such as peptides, and large polypeptides, such as antibodies. The firm offers clinical stage development for treatment of cancer to diagnose advance programs.
Who invested in Ratio Therapeutics
5 investors across 1 round
See all investors in Ratio Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jul 16, 2026
Amount
$70M
Investors
Questions about Ratio Therapeutics
Who invested in Ratio Therapeutics?
Ratio Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ratio Therapeutics raised?
Ratio Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ratio Therapeutics last raise money?
Ratio Therapeutics's most recent round on record is a Series C, in Jul 2026.
What does Ratio Therapeutics do?
Based in Massachusetts, US, and founded in 2021 by CEO Jack Hoppin and Director John Babich, Ratio Therapeutics, Inc.
Where is Ratio Therapeutics headquartered?
Ratio Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Ratio Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Ratio Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Ratio Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.